33 C
New York
Thursday, June 11, 2026

Tag: European Union

UK Imports of Italian Canned Tomatoes Reach Record Levels

 Their premium quality, health benefits and versatility win over British catering professionals and consumers.NAPLES, Italy, June 11, 2026 /PRNewswire/ -- The Red Gold from...

Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance

Cosmos Health secures additional 180-day Nasdaq extension to regain compliance.

newcleo Strengthens U.S. Leadership Team with Strategic Appointments of Dustin Greenwood and Travis Chapman

Industry veterans bring deep expertise in advanced reactor deployment, nuclear operations and regulatory licensing to support company’s U.S. growth
Industry veterans bring deep expertise in advanced reactor deployment, nuclear operations and regulatory licensing to support company’s U.S. growth

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Slovak Prime Minister Meets WeRide, Signals Support for Multi-Product Autonomous Vehicle Deployment

WeRide outlined plans to commercialize its L4 AV portfolio in Slovakia during a meeting with His Excellency Mr. Robert Fico Prime Minister of Slovakia.

ING rolls out global subscription banking model

ING rolls out global subscription banking model

FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the startINDIANAPOLIS,...

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

- A word from our sponsors -

spot_img
HomeTagsEuropean Union